An erythroid differentiation signature predicts response to lenalidomide in Myelodysplastic Syndrome
No citation available. Published: 2008.01.31
Benjamin L. Ebert, Naomi Galili, Pablo Tamayo, Jocelyn Bosco, Raymond Mak, Jennifer Pretz, Christine Ladd-Acosta, Richard Stone, Todd R. Golub and Azra Raza.
Abstract
No abstract available
Keywords: Myelodysplastic Syndrome (MDS) erythroid differentiation hematopoietic disorder lenalidomide revlimid
Supplemental Data
| Description | Link/Filename |
|---|---|
| Datasets files and prediction program (R script) | Revlimid_files_and_program.zip |
| Sample annotation file | journal.pmed.0050035.st001.xls |
| CEL files | revlimid_files (1).zip |